186 related articles for article (PubMed ID: 21170957)
1. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
[TBL] [Abstract][Full Text] [Related]
4. AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients.
Evdokimova VN; Liu Y; Potter DM; Butterfield LH
J Immunother; 2007; 30(4):425-37. PubMed ID: 17457217
[TBL] [Abstract][Full Text] [Related]
5. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S
Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
[TBL] [Abstract][Full Text] [Related]
7. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer.
Liu Y; Daley S; Evdokimova VN; Zdobinski DD; Potter DM; Butterfield LH
J Immunol; 2006 Jul; 177(1):712-21. PubMed ID: 16785570
[TBL] [Abstract][Full Text] [Related]
8. Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization.
Ayaru L; Pereira SP; Alisa A; Pathan AA; Williams R; Davidson B; Burroughs AK; Meyer T; Behboudi S
J Immunol; 2007 Feb; 178(3):1914-22. PubMed ID: 17237442
[TBL] [Abstract][Full Text] [Related]
9. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
10. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC
Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
[TBL] [Abstract][Full Text] [Related]
12. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
13. Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.
Hanke P; Rabe C; Serwe M; Böhm S; Pagenstecher C; Sauerbruch T; Caselmann WH
Scand J Gastroenterol; 2002 Aug; 37(8):949-55. PubMed ID: 12229971
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
Butterfield LH; Ribas A; Potter DM; Economou JS
Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860
[TBL] [Abstract][Full Text] [Related]
15. Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Flecken T; Schmidt N; Hild S; Gostick E; Drognitz O; Zeiser R; Schemmer P; Bruns H; Eiermann T; Price DA; Blum HE; Neumann-Haefelin C; Thimme R
Hepatology; 2014 Apr; 59(4):1415-26. PubMed ID: 24002931
[TBL] [Abstract][Full Text] [Related]
16. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.
Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M
Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Mukaida N; Matsushima K; Matsui O; Kaneko S
Int J Cancer; 2010 May; 126(9):2164-74. PubMed ID: 19739081
[TBL] [Abstract][Full Text] [Related]
18. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
Butterfield LH; Ribas A; Meng WS; Dissette VB; Amarnani S; Vu HT; Seja E; Todd K; Glaspy JA; McBride WH; Economou JS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5902-8. PubMed ID: 14676113
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
20. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
Greten TF; Ormandy LA; Fikuart A; Höchst B; Henschen S; Hörning M; Manns MP; Korangy F
J Immunother; 2010; 33(2):211-8. PubMed ID: 20139774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
